evaluating the changes in chest magnetic resonance imaging (MRI) three months after the
start of elexacaftor/tezacaftor and ivacaftor therapy. MRI showed a drastic reduction in
mucus plugging and bronchial wall thickening, with an improvement in the diffusion-
weighted MRI score. Similarly, a marked improvement in spirometric parameters, nutritional
status, and sweat chloride was observed. Our preliminary data confirm that chest MRI could …